Fluorescein sodium

Revision as of 17:22, 12 January 2015 by Gloria Picoy (talk | contribs) (Created page with "{{DrugProjectFormSinglePage |authorTag={{GP}} |genericName=Fluorescein sodium |drugClass=disclosing agent |indication= in diagnostic fluorescein angiography or angioscopy of t...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Fluorescein sodium
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gloria Picoy [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Fluorescein sodium is {{{aOrAn}}} disclosing agent that is FDA approved for the {{{indicationType}}} of in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature. Common adverse reactions include skin discoloration, urine discoloration, nausea, vomiting, and gastrointestinal distress.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Fluorescein sodium FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Fluorescein sodium in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Fluorescein sodium in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Fluorescein sodium FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Fluorescein sodium in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Fluorescein sodium in pediatric patients.

Contraindications

There is limited information regarding Fluorescein sodium Contraindications in the drug label.

Warnings

There is limited information regarding Fluorescein sodium Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Fluorescein sodium Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Fluorescein sodium Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Fluorescein sodium Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Fluorescein sodium in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Fluorescein sodium in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Fluorescein sodium during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Fluorescein sodium in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Fluorescein sodium in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Fluorescein sodium in geriatric settings.

Gender

There is no FDA guidance on the use of Fluorescein sodium with respect to specific gender populations.

Race

There is no FDA guidance on the use of Fluorescein sodium with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Fluorescein sodium in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Fluorescein sodium in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Fluorescein sodium in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Fluorescein sodium in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Fluorescein sodium Administration in the drug label.

Monitoring

There is limited information regarding Fluorescein sodium Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Fluorescein sodium and IV administrations.

Overdosage

There is limited information regarding Fluorescein sodium overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Fluorescein sodium Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Fluorescein sodium Mechanism of Action in the drug label.

Structure

There is limited information regarding Fluorescein sodium Structure in the drug label.

Pharmacodynamics

There is limited information regarding Fluorescein sodium Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Fluorescein sodium Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Fluorescein sodium Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Fluorescein sodium Clinical Studies in the drug label.

How Supplied

There is limited information regarding Fluorescein sodium How Supplied in the drug label.

Storage

There is limited information regarding Fluorescein sodium Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Fluorescein sodium |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Fluorescein sodium |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Fluorescein sodium Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Fluorescein sodium interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Fluorescein sodium Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Fluorescein sodium Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.